SEC Insider Transactions from Hoffman Robert E..

Last updated: 2026-03-24 23:02 UTC | Total transactions: 9

Hoffman Robert E. has filed 9 insider transactions across 4 companies since August 2024.

Most recent transaction: a grant/award of 4874691 shares of CytoDyn Inc. ($CYDY) on March 20, 2026.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
March 20, 2026 CytoDyn Inc. $CYDY Hoffman Robert E. Chief Financial Officer A Non-qualified stock option (right to buy) 4874691 $0.00 4,874,691.0000 1,261,016,000 9999.99% 0.39%
Feb. 12, 2026 TuHURA Biosciences, Inc./NV $HURA Hoffman Robert E. Not found A Options (Right to Buy) 156240 $0.00 207,515.0000 51,258,085 304.71% 0.30%
June 12, 2025 FibroBiologics, Inc. $FBLG Hoffman Robert E. Director A Stock Option (Right to Buy) 22000 $0.00 22,000.0000 37,735,300 9999.99% 0.06%
May 29, 2025 Esperion Therapeutics, Inc. $ESPR Hoffman Robert E. Director A Common Stock 5280 $0.00 5,280.0000 197,848,886 9999.99% 0.00%
May 29, 2025 Esperion Therapeutics, Inc. $ESPR Hoffman Robert E. Director A Stock Option (right to buy) 7040 $0.00 7,040.0000 197,848,886 9999.99% 0.00%
May 15, 2025 CytoDyn Inc. $CYDY Hoffman Robert E. Chief Financial Officer A Non-qualified stock option (right to buy) 1000000 $0.00 1,000,000.0000 1,228,259,000 9999.99% 0.08%
April 1, 2025 Esperion Therapeutics, Inc. $ESPR Hoffman Robert E. Director A Stock Option (right to buy) 40000 $0.00 40,000.0000 197,848,886 9999.99% 0.02%
Jan. 2, 2025 TuHURA Biosciences, Inc./NV $HURA Hoffman Robert E. Not found A Options (Right to Buy) 51275 $0.00 51,275.0000 0 9999.99% 0.00%
Aug. 27, 2024 FibroBiologics, Inc. $FBLG Hoffman Robert E. Director A Stock Option (Right to Buy) 5000 $0.00 5,000.0000 0 9999.99% 0.00%